LSAM-Cisplatin (Nanology)

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameLSAM-Cisplatin (Nanology)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursLung NeoplasmsBrain Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanology Llc
China Registration ClassN/A

Develop Information

Active CompaniesNanology Llc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLung NeoplasmsBrain Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A